18
Views
28
CrossRef citations to date
0
Altmetric
Review

Radioimmunotherapy of non-Hodgkin’s lymphoma: a critical appraisal

, &
Pages 47-62 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

David M. Goldenberg & Robert M. Sharkey. (2010) Radioactive Antibodies: A Historical Review of Selective Targeting and Treatment of Cancer. Hospital Practice 38:3, pages 82-93.
Read now
David M Goldenberg. (2006) Epratuzumab in the therapy of oncological and immunological diseases. Expert Review of Anticancer Therapy 6:10, pages 1341-1353.
Read now
Robert M. Sharkey & David M. Goldenberg. (2006) Advances in Radioimmunotherapy in the Age of Molecular Engineering and Pretargeting. Cancer Investigation 24:1, pages 82-97.
Read now

Articles from other publishers (25)

Rohit Sharma, Shishu K. Suman & Archana Mukherjee. (2022) Antibody-based Radiopharmaceuticals as Theranostic Agents: An Overview. Current Medicinal Chemistry 29:38, pages 5979-6005.
Crossref
Shishu Kant Suman, Rohit Sharma & Chandan Kumar. 2021. Immunodiagnostic Technologies from Laboratory to Point-Of-Care Testing. Immunodiagnostic Technologies from Laboratory to Point-Of-Care Testing 61 74 .
Eric W. Price & Chris Orvig. 2014. The Chemistry of Molecular Imaging. The Chemistry of Molecular Imaging 105 135 .
Eric W. Price & Chris Orvig. (2014) Matching chelators to radiometals for radiopharmaceuticals. Chem. Soc. Rev. 43:1, pages 260-290.
Crossref
Alexander Koshkaryev, Rupa Sawant, Madhura Deshpande & Vladimir Torchilin. (2013) Immunoconjugates and long circulating systems: Origins, current state of the art and future directions. Advanced Drug Delivery Reviews 65:1, pages 24-35.
Crossref
C. Andrew Boswell, Eduardo E. Mundo, Crystal Zhang, Shannon L. Stainton, Shang-Fan Yu, Jennifer A. Lacap, Weiguang Mao, Katherine R. Kozak, Aimee Fourie, Paul Polakis, Leslie A. Khawli & Kedan Lin. (2012) Differential Effects of Predosing on Tumor and Tissue Uptake of an 111 In-Labeled Anti-TENB2 Antibody–Drug Conjugate . Journal of Nuclear Medicine 53:9, pages 1454-1461.
Crossref
Eric W. Price, Jacqueline F. Cawthray, Gwendolyn A. Bailey, Cara L. Ferreira, Eszter Boros, Michael J. Adam & Chris Orvig. (2012) H 4 octapa: An Acyclic Chelator for 111 In Radiopharmaceuticals . Journal of the American Chemical Society 134:20, pages 8670-8683.
Crossref
David M. Goldenberg & Robert M. Sharkey. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine 125 138 .
Laurent Ducry. 2011. Drug Delivery in Oncology. Drug Delivery in Oncology 355 374 .
Saileta Prabhu, C Andrew Boswell, Douglas Leipold, Leslie A Khawli, Dongwei Li, Dan Lu, Frank-Peter Theil, Amita Joshi & Bert L Lum. (2011) Antibody delivery of drugs and radionuclides: factors influencing clinical pharmacology. Therapeutic Delivery 2:6, pages 769-791.
Crossref
Robert M Sharkey & David M Goldenberg. (2011) Cancer radioimmunotherapy. Immunotherapy 3:3, pages 349-370.
Crossref
Kwon Yong & Martin W. Brechbiel. (2011) Towards translation of 212Pb as a clinical therapeutic; getting the lead in!. Dalton Transactions 40:23, pages 6068.
Crossref
Katharina Frey & Dario Neri. 2011. Tumor-Associated Fibroblasts and their Matrix. Tumor-Associated Fibroblasts and their Matrix 419 450 .
Robert M. Sharkey & David G. Goldenberg. 2010. Monoclonal Antibody and Peptide‐Targeted Radiotherapy of Cancer. Monoclonal Antibody and Peptide‐Targeted Radiotherapy of Cancer 241 287 .
Serengulam V. Govindan & David M. Goldenberg. 2010. Macromolecular Anticancer Therapeutics. Macromolecular Anticancer Therapeutics 371 392 .
K. Sadri, M. Gandomkar, M. H. Babaei, R. Najafi, S. R. Zakavi & S. E. Sadat Ebrahimi. (2009) Synthesis and biodistribution studies of iodine-131 D-amino acid YYK peptide as a potential therapeutic agent for labeling an anti-CD20 antibody. Journal of Labelled Compounds and Radiopharmaceuticals 52:7, pages 289-294.
Crossref
T. Barrett, G. Ravizzini, P. Choyke & H. Kobayashi. (2009) Dendrimers in medical nanotechnology. IEEE Engineering in Medicine and Biology Magazine 28:1, pages 12-22.
Crossref
Robert M. Sharkey, Habibe Karacay, Samuel Litwin, Edmund A. Rossi, William J. McBride, Chien-Hsing Chang & David M. Goldenberg. (2008) Improved Therapeutic Results by Pretargeted Radioimmunotherapy of Non–Hodgkin's Lymphoma with a New Recombinant, Trivalent, Anti-CD20, Bispecific Antibody. Cancer Research 68:13, pages 5282-5290.
Crossref
Pavitra ChakravartyRadu MarchesNeil S. Zimmerman, Austin D.-E. Swafford, Pooja Bajaj, Inga H. Musselman, Paul Pantano, Rockford K. Draper & Ellen S. Vitetta. (2008) Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubes. Proceedings of the National Academy of Sciences 105:25, pages 8697-8702.
Crossref
C. Andrew Boswell & Martin W. Brechbiel. (2007) Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view. Nuclear Medicine and Biology 34:7, pages 757-778.
Crossref
Pierre-Yves Brard, Habibe Karacay, Rhona Stein, Robert M. Sharkey, M. Jules Mattes, Chien-Hsing Chang, Edmund A. Rossi, William J. McBride & David M. Goldenberg. (2007) A Divalent Hapten-Peptide Induces Apoptosis in Human Non–Hodgkin Lymphoma Cell Lines Targeted by Anti-CD20 × Anti-Hapten Bispecific Antibodies. Clinical Cancer Research 13:18, pages 5564s-5571s.
Crossref
J P Leonard & D M Goldenberg. (2007) Preclinical and clinical evaluation of epratuzumab (anti-CD22 IgG) in B-cell malignancies. Oncogene 26:25, pages 3704-3713.
Crossref
David M. Goldenberg, Robert M. Sharkey, Jacques Barbet & Jean-Francois Chatal. (2007) Radioactive antibodies: Selective targeting and treatment of cancer and other diseases. Applied Radiology, pages 10-29.
Crossref
Ruby F. Meredith. (2006) Ongoing investigations and new uses of radioimmunotherapy in the treatment of non-Hodgkin’s lymphoma. International Journal of Radiation Oncology*Biology*Physics 66:2, pages S23-S29.
Crossref
David M. Goldenberg, Robert M. Sharkey, Giovanni Paganelli, Jacques Barbet & Jean-François Chatal. (2006) Antibody Pretargeting Advances Cancer Radioimmunodetection and Radioimmunotherapy. Journal of Clinical Oncology 24:5, pages 823-834.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.